Raderer M - Search Results

1

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study.

Robak T, Jin J, Pylypenko H, Verhoef G, Siritanaratkul N, Drach J, Raderer M, Mayer J, Pereira J, Tumyan G, Okamoto R, Nakahara S, Hu P, Appiani C, Nemat S, Cavalli F; LYM-3002 investigators. Robak T, et al. Among authors: raderer m. Lancet Oncol. 2018 Nov;19(11):1449-1458. doi: 10.1016/S1470-2045(18)30685-5. Epub 2018 Oct 19. Lancet Oncol. 2018. PMID: 30348538 Clinical Trial.

2

Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure l-isomer of leucovorin for the treatment of advanced colorectal cancer: a randomized phase III study.

Scheithauer W, Kornek G, Marczell A, Salem G, Karner J, Kovats E, Burger D, Greiner R, Pidlich J, Schneeweiss B, Raderer M, Rosen H, Depisch D. Scheithauer W, et al. Among authors: raderer m. J Clin Oncol. 1997 Mar;15(3):908-14. doi: 10.1200/JCO.1997.15.3.908. J Clin Oncol. 1997. PMID: 9060527 Clinical Trial.

3

Treatment of advanced colorectal cancer with doxorubicin combined with two potential multidrug-resistance-reversing agents: high-dose oral tamoxifen and dexverapamil.

Weinländer G, Kornek G, Raderer M, Hejna M, Tetzner C, Scheithauer W. Weinländer G, et al. Among authors: raderer m. J Cancer Res Clin Oncol. 1997;123(8):452-5. doi: 10.1007/BF01372550. J Cancer Res Clin Oncol. 1997. PMID: 9292709 Free PMC article. Clinical Trial.

4

Treatment of advanced pancreatic cancer with epirubicin, 5-fluorouracil and 1-leucovorin: a phase II study.

Raderer M, Kornek GV, Hejna MH, Weinlaender G, Vorbeck F, Fiebiger WC, Scheithauer W. Raderer M, et al. Ann Oncol. 1997 Aug;8(8):797-9. doi: 10.1023/a:1008276004552. Ann Oncol. 1997. PMID: 9332689 Free article. Clinical Trial.

5

Mitomycin C, vinorelbine, carboplatin plus granulocyte-macrophage colony-stimulating factor for treatment of advanced non-small cell lung carcinoma.

Hejna M, Kornek GV, Raderer M, Marosi L, Schneeweiss B, Greul R, Weinländer G, Valencak J, Huber H, Scheithauer W. Hejna M, et al. Among authors: raderer m. Oncology. 1998 Nov-Dec;55(6):538-42. doi: 10.1159/000011909. Oncology. 1998. PMID: 9778620 Clinical Trial.

6

5-methyltetrahydrofolate for biochemical modulation of fluorouracil (FU) in patients with advanced colorectal cancer: a randomized phase I-II study of two different FU administration schedules.

Hejna M, Kornek GV, Raderer M, Valencak J, Weinländer G, Fiebiger W, Miholic J, Scheithauer W. Hejna M, et al. Among authors: raderer m. Ann Oncol. 1998 Dec;9(12):1309-14. doi: 10.1023/a:1008448214105. Ann Oncol. 1998. PMID: 9932161 Free article. Clinical Trial.

7

Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer.

Raderer M, Hejna MH, Valencak JB, Kornek GV, Weinländer GS, Bareck E, Lenauer J, Brodowicz T, Lang F, Scheithauer W. Raderer M, et al. Oncology. 1999 Apr;56(3):177-80. doi: 10.1159/000011961. Oncology. 1999. PMID: 10202270 Clinical Trial.

8

Chemotherapy for the treatment of patients with primary high grade gastric B-cell lymphoma of modified Ann Arbor Stages IE and IIE.

Raderer M, Valencak J, Osterreicher C, Drach J, Hejna M, Kornek G, Scheithauer W, Brodowicz T, Chott A, Dragosics B. Raderer M, et al. Cancer. 2000 May 1;88(9):1979-85. doi: 10.1002/(sici)1097-0142(20000501)88:9<1979::aid-cncr1>3.0.co;2-l. Cancer. 2000. PMID: 10813708

9

Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma.

Welzel N, Le T, Marculescu R, Mitterbauer G, Chott A, Pott C, Kneba M, Du MQ, Kusec R, Drach J, Raderer M, Mannhalter C, Lechner K, Nadel B, Jaeger U. Welzel N, et al. Among authors: raderer m. Cancer Res. 2001 Feb 15;61(4):1629-36. Cancer Res. 2001. PMID: 11245476

10

Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer.

Penz M, Kornek GV, Raderer M, Ulrich-Pur H, Fiebiger W, Lenauer A, Depisch D, Krauss G, Schneeweiss B, Scheithauer W. Penz M, et al. Among authors: raderer m. Ann Oncol. 2001 Feb;12(2):183-6. doi: 10.1023/a:1008352123009. Ann Oncol. 2001. PMID: 11300321 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

432 results

Search Page

Filters